HDAC6 and multiple sclerosis: Conversely, inhibition of HDAC6 or PANX1 attenuates disease progression in some inflammatory and/or autoimmune mouse models (e.g., arthritis, multiple sclerosis)58–60, and HDAC6 negatively regulates activity of CD4+ Foxp3+ regulatory T cells61.